These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9380984)

  • 1. [Myelodysplastic syndromes].
    Raza A; Vadhan-Raj S; Chávez-Sánchez G
    Rev Invest Clin; 1997 May; 49 Suppl 1():15-21. PubMed ID: 9380984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary myelodysplastic syndromes].
    Brohée D
    Rev Med Brux; 1988 Sep; 9(6):327-33. PubMed ID: 3051250
    [No Abstract]   [Full Text] [Related]  

  • 3. The study and treatment of the myelodysplastic patient.
    Sanz MA; Bennett JM; Vallespí T; Hoelzer D
    Rev Invest Clin; 1994 Apr; Suppl():61-73. PubMed ID: 7886312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biology and clinical aspects of primary myelodysplastic syndromes].
    Urbańska-Ryś H; Robak T; Krykowski E
    Pol Tyg Lek; 1988 Feb; 43(7):225-9. PubMed ID: 3043403
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
    Hast R; Bernell P
    Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acute myelogenous leukemia and myelodysplastic syndromes.
    Estey EH
    Semin Hematol; 1995 Apr; 32(2):132-51. PubMed ID: 7652581
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelodysplastic syndromes--diagnostic and therapeutic problems].
    Skotnicki AB; Piatkowska-Jakubas B; Rucińska M; Zduńczyk A
    Przegl Lek; 1988; 45(11):801-11. PubMed ID: 3072594
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical use of hematopoietic growth factors.
    Löwenberg B; Dale DC; Sheridan WP
    Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of adult myelodysplastic syndromes.
    Hellström-Lindberg E
    Int J Hematol; 1999 Oct; 70(3):141-54. PubMed ID: 10561906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes.
    Greenberg PL
    Semin Hematol; 1996 Apr; 33(2):163-75. PubMed ID: 8722686
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of hematopoietic growth factors on extensive apoptosis of myelodysplastic hematopoietic cells and its clinical significance].
    Cao Z; Li R; Li Q
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):27-30. PubMed ID: 10921099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
    Guidetti F; Grazioli S; Capelli F; Marini C; Gallicchio M; De Micheli D; Castello L; Sainaghi PP; Fra GP; Saglio G; Avanzi GC
    Haematologica; 2004 Jan; 89(1):21-8. PubMed ID: 14754602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based therapy for myelodysplastic syndrome].
    Toyama K
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):992-8. PubMed ID: 12866444
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-azacitidine: An alternative treatment of myelodysplastic syndromes in patient with refractory response to hematopoietic growth factor, a case report and review of literatures.
    Suwanawiboon B; Sumida KN
    Hawaii Med J; 2004 Jan; 63(1):14-6, 25. PubMed ID: 15011897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
    Gassmann W; Schmitz N; Löffler H; De Witte T
    Semin Hematol; 1996 Jul; 33(3):196-205. PubMed ID: 8819230
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging therapeutic strategies for myelodysplastic syndrome.
    Barrett J; Battiwalla M
    Curr Hematol Rep; 2003 May; 2(3):193-201. PubMed ID: 12901340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
    Ganser A; Hoelzer D
    Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
    [No Abstract]   [Full Text] [Related]  

  • 19. Biology and treatment of myelodysplastic syndromes--developments in the past decade.
    Willemze R; Fibbe WE; Falkenburg JH; Kluin-Nelemans JC; Kluin PM; Landegent JE
    Ann Hematol; 1993 Mar; 66(3):107-15. PubMed ID: 8471655
    [No Abstract]   [Full Text] [Related]  

  • 20. Biology of stem and myeloid progenitor cells in myelodysplastic syndromes.
    Span LF; de Witte TM
    Cancer Treat Res; 2001; 108():45-63. PubMed ID: 11702605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.